msadmin
Insilico and SK Biopharm ink $2.5 billion AI drug discovery deal
The partnership targets neuroimmune and CNS disorders using Insilico's Pharma.AI engine, with $18 million in upfront payments and milestone-based upside.
Drug metabolism AI contest shows data matters more than model size
Inductive Bio won the openADMET competition, but a 28-way statistical tie suggests data quality may trump model architecture for predicting…
Insilico and Bora Pharma bring generative AI to drug manufacturing
The alliance extends Insilico's PandaOmics and Chemistry42 platforms into pharmaceutical manufacturing for the first time, targeting a $168B CDMO industry.
Senators Blumenthal and Hawley probe Medicare Advantage insurers over AI denials
In a rare bipartisan move, the senators demand internal records from UnitedHealth, Humana, and CVS on the use of AI…
Bigger AI models don’t always win in drug metabolism prediction
The OpenADMET challenge found that smaller, specialized models matched or beat large foundation models at predicting how the body processes…
AI model predicts immunotherapy response across cancer types
COMPASS, a pan-cancer foundation model, outperforms 22 methods across 16 clinical cohorts by analyzing tumor transcriptomes through immune concepts.
Singapore heart centre AI cuts cardiac damage reading to one minute
CARDIA-GM analyzes cardiac MRI scans in under 60 seconds, detecting scarred tissue and microvascular obstruction after heart attacks.
First Canadian ALS patient receives Neuralink brain implant
Vancouver police sergeant Lee Marten can control his phone and laptop with his thoughts after Neuralink surgery in Toronto.